Tandem Diabetes Stock Forecast
For the next financial year, analysts expect that the business will post earnings of $0.81 per share, with eps estimates ranging from $0.45 to $1.06. View the latest tandem diabetes care inc.
(tndm) stock price, news, historical charts, analyst ratings and financial information from wsj.
Tandem diabetes stock forecast. 10, 2021 at 10:00 a.m. A target price of $139.000000; Exploring tandem diabetes care (tndm) stock?
We're pleased to report that tandem diabetes care shareholders have received a total shareholder return of 33% over one year. As an investor, you can get an idea of where the stock is trending by the forecast and beta. Tandem diabetes care inc stock forecast.
Based on the tandem diabetes care inc stock forecasts from 7 analysts, the average analyst target price for tandem. If you aren't focused on one strategy, this score is the one you should be interested in. The average tandem diabetes care stock price prediction forecasts a potential downside of n/a from the current tndm share price of $138.88.
Is currently rated as a zacks rank 3 and we are. Analysts estimate that tandem diabetes care will likely report an earnings per share (eps) of $0.06. View tndm's stock price, price target, dividend, earnings, financials, forecast, insider trades, and sec filings at stockearnings.
Tandem diabetes care bulls will hope to hear. Here's why tandem diabetes care, inc. Tandem diabetes care inc has risen higher in 4 of those 7 years over the subsequent 52 week period, corresponding to a historical accuracy of 57.14 %
On average, wall street analysts predict that. Beta is calculated using regression analysis. Insiders pound the table on these two stocks november 8, 2021 tipranks tandem diabetes care (tndm) gets a hold rating from robert w.
Tndm | tandem diabetes care inc. Insulin pump producer tandem diabetes care, inc. Notably, tandem diabetes care, inc.
Tandem diabetes care their estimated earnings by 50.0%, reporting an eps of $0.09 versus an estimate of $0.06, which surprised analysts. Zacks' proprietary data indicates that tandem diabetes care, inc. Et on zacks.com essex investment management co llc buys tandem diabetes care inc, solaredge.
According to zacks, analysts expect that tandem diabetes care will report full year earnings of $0.31 per share for the current fiscal year, with eps estimates ranging from $0.24 to $0.37. The company s flagship product is the t:slim insulin delivery system that comprises t:slim pump, its disposable insulin cartridge, and an infusion set. Over the next 52 weeks, tandem diabetes care inc has on average historically risen by 162.2 % based on the past 7 years of stock performance.
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions has been net zero. Has a zacks rank #3 (hold). (tndm) is a strong momentum stock nov.
Overall, the stock has an aggregate vgm score of b. (tndm) delivered earnings and revenue surprises of 53.33% and 14.98%, respectively, for the quarter ended march 2021. The number of outstanding shares for tandem diabetes care inc is 63029000.
(tndm) reports q1 loss, tops revenue estimates. Tandem diabetes care inc’s stock price has changed by +1.52 % over the past week, +5.71 % over the past month and +31.39 % over the last year. (nasdaq:tndm), which ranks eighth in our list of 10 best diabetes stocks to buy now, recently saw an.
Tndm has a momentum style. Tandem diabetes care's share price could stay at $118.25 by nov 4, 2022. Tndm is a #3 (hold) on the zacks rank, with a vgm score of a.
Now that you know more about tandem diabetes care inc stands, let’s learn more about the future of the company. Baird november 4, 2021 tipranks profile Lowering target price to $139.00 tandem diabetes care inc has an investment rating of hold;
Momentum investors should take note of this medical stock.
Post a Comment for "Tandem Diabetes Stock Forecast"